HMC

Harvard Management Company Portfolio holdings

AUM $1.44B
This Quarter Return
-20.41%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$864M
AUM Growth
+$864M
Cap. Flow
+$101M
Cap. Flow %
11.75%
Top 10 Hldgs %
81.94%
Holding
45
New
1
Increased
11
Reduced
1
Closed

Sector Composition

1 Communication Services 51.63%
2 Healthcare 17.75%
3 Consumer Discretionary 14.57%
4 Technology 12.1%
5 Industrials 2.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TNYA icon
26
Tenaya Therapeutics
TNYA
$184M
$3.79M 0.44%
673,270
RKLB icon
27
Rocket Lab Corporation Common Stock
RKLB
$23.4B
$3.79M 0.44%
1,000,000
GBIO icon
28
Generation Bio
GBIO
$40.4M
$3.35M 0.39%
510,354
TNGX icon
29
Tango Therapeutics
TNGX
$747M
$3.21M 0.37%
708,385
AFRM icon
30
Affirm
AFRM
$28.8B
$3.13M 0.36%
173,560
CFLT icon
31
Confluent
CFLT
$6.85B
$3.03M 0.35%
130,383
SANA icon
32
Sana Biotechnology
SANA
$777M
$3.01M 0.35%
468,749
SRZN icon
33
Surrozen
SRZN
$104M
$2.43M 0.28%
826,852
FULC icon
34
Fulcrum Therapeutics
FULC
$351M
$2.01M 0.23%
410,714
PRAX icon
35
Praxis Precision Medicines
PRAX
$958M
$1.91M 0.22%
778,517
PCTTW
36
PureCycle Technologies, Inc. Warrant
PCTTW
$844M
$1.89M 0.22%
714,285
DBTX
37
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.38M 0.16%
328,798
PRDS
38
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.23M 0.14%
400,000
XLO icon
39
Xilio Therapeutics
XLO
$36.3M
$1.22M 0.14%
416,059
PACB icon
40
Pacific Biosciences
PACB
$393M
$1.01M 0.12%
229,144
VIGL
41
DELISTED
Vigil Neuroscience
VIGL
$747K 0.09%
289,460
DYN icon
42
Dyne Therapeutics
DYN
$1.92B
$737K 0.09%
107,252
MCRB icon
43
Seres Therapeutics
MCRB
$166M
$452K 0.05%
131,847
IRON icon
44
Disc Medicine
IRON
$2.07B
$423K 0.05%
250,000
DNTH icon
45
Dianthus Therapeutics
DNTH
$759M
$399K 0.05%
332,610